BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 19562690)

  • 1. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions.
    Perrone L; Devi TS; Hosoya K; Terasaki T; Singh LP
    J Cell Physiol; 2009 Oct; 221(1):262-72. PubMed ID: 19562690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
    Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
    Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion.
    Sbai O; Devi TS; Melone MA; Feron F; Khrestchatisky M; Singh LP; Perrone L
    J Cell Sci; 2010 Dec; 123(Pt 24):4332-9. PubMed ID: 21098642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy.
    Zheng L; Howell SJ; Hatala DA; Huang K; Kern TS
    Diabetes; 2007 Feb; 56(2):337-45. PubMed ID: 17259377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 MAPK pathway is involved in high glucose-induced thioredoxin interacting protein induction in mouse mesangial cells.
    Ren Y; Shi Y; Wang Y; Li Y; Wu S; Li H; Zhang Y; Duan H
    FEBS Lett; 2010 Aug; 584(15):3480-5. PubMed ID: 20624390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina.
    Mohammad G; Siddiquei MM; Othman A; Al-Shabrawey M; Abu El-Asrar AM
    Exp Eye Res; 2013 Feb; 107():101-9. PubMed ID: 23261684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thioredoxin interacting protein is increased in sensory neurons in experimental diabetes.
    Price SA; Gardiner NJ; Duran-Jimenez B; Zeef LA; Obrosova IG; Tomlinson DR
    Brain Res; 2006 Oct; 1116(1):206-14. PubMed ID: 16938273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.
    Yamagishi S; Matsui T; Nakamura K; Inoue H; Takeuchi M; Ueda S; Fukami K; Okuda S; Imaizumi T
    Microvasc Res; 2008 Jan; 75(1):130-4. PubMed ID: 17560613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the sphingosine kinase-signaling pathway by high glucose mediates the proinflammatory phenotype of endothelial cells.
    Wang L; Xing XP; Holmes A; Wadham C; Gamble JR; Vadas MA; Xia P
    Circ Res; 2005 Oct; 97(9):891-9. PubMed ID: 16179586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment.
    Saccani S; Pantano S; Natoli G
    Nat Immunol; 2002 Jan; 3(1):69-75. PubMed ID: 11743587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLC/CAMK IV-NF-kappaB involved in the receptor for advanced glycation end products mediated signaling pathway in human endothelial cells.
    You J; Peng W; Lin X; Huang QL; Lin JY
    Mol Cell Endocrinol; 2010 May; 320(1-2):111-7. PubMed ID: 20171262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitriol blunts pro-atherosclerotic parameters through NFkappaB and p38 in vitro.
    Talmor Y; Bernheim J; Klein O; Green J; Rashid G
    Eur J Clin Invest; 2008 Aug; 38(8):548-54. PubMed ID: 18717824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.
    Ma W; Lee SE; Guo J; Qu W; Hudson BI; Schmidt AM; Barile GR
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1355-61. PubMed ID: 17325184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
    Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIOM-79 inhibits high glucose or AGEs-induced VEGF expression in human retinal pigment epithelial cells.
    Kim YS; Jung DH; Kim NH; Lee YM; Jang DS; Song GY; Kim JS
    J Ethnopharmacol; 2007 May; 112(1):166-72. PubMed ID: 17383127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of aspirin against oxidized LDL-induced inflammatory protein expression in human endothelial cells.
    Zhao J; Qi R; Li R; Wu W; Gao X; Bao L; Lu S
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):32-7. PubMed ID: 18209566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAGE in inflammation: a new therapeutic target?
    Bierhaus A; Stern DM; Nawroth PP
    Curr Opin Investig Drugs; 2006 Nov; 7(11):985-91. PubMed ID: 17117586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.
    Yonekura H; Yamamoto Y; Sakurai S; Petrova RG; Abedin MJ; Li H; Yasui K; Takeuchi M; Makita Z; Takasawa S; Okamoto H; Watanabe T; Yamamoto H
    Biochem J; 2003 Mar; 370(Pt 3):1097-109. PubMed ID: 12495433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral administration of grape seed proanthocyanidin extracts downregulate RAGE dependant nuclear factor- kappa BP65 expression in the hippocampus of streptozotocin induced diabetic rats.
    Xu L; Li B; Cheng M; Zhang W; Pan J; Zhang C; Gao H
    Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):215-24. PubMed ID: 18273752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.